Biofilm infections are exceptionally recalcitrant to antimicrobial treatment or clearance by host immune responses. Within biofilms, microbes form adherent multicellular communities that are embedded in an extracellular matrix. Many prescribed antifungal drugs are not effective against biofilm infections owing to several protective factors including poor diffusion of drugs through biofilms as well as specific drug-matrix interactions. Despite the key roles that biofilms play in infections, there is little quantitative information about their composition and structural complexity because of the analytical challenge of studying these dense networks using traditional techniques. Within this review, recent work to elucidate fungal biofilm composition is discussed, with particular attention given to the challenges of annotation and quantification of matrix composition. 
unknown [19, 21] . Functionally, the ECM can serve as a protective barrier against chemical and biological antimicrobial agents including many prescribed antifungal drugs ( Figure 1A ) [5, [19] [20] [21] . In some instances, ECM can contribute to antifungal resistance by binding to antifungals, thereby preventing access to their intended target at the surface or within fungal cells [16, [24] [25] [26] [27] [28] [29] . As such, a better understanding of ECM composition is key to understanding the specific mechanisms of antifungal resistance exhibited by biofilm formers. Antifungal resistance has been studied extensively for C. albicans, and in some cases Candida biofilms have been found to be capable of withstanding antifungal concentrations that are 1000-fold higher than those that inhibit planktonic cells [5, [30] [31] [32] . The presence of β-1,3-glucans in the ECM partially can explain this remarkable level of resistance as β-1,3-glucans can interact with a number of antimicrobials [33] [34] [35] [36] [37] . For example, radio-labeled fluconazole was found to be sequestered by ECM, which was correlated with the quantity of β-1,3-glucans in the matrix [30] . β-1,3-glucans can also interact with amphotericin B, flucytosine and echinocandins [30] . Interestingly, biofilm resistance to echinocandins is lower as compared with other antifungals, and it has been hypothesized that this may be because echinocandins impair β-1,3-glucan synthesis [30] . Indeed, mutants unable to produce the enzymes that transfer glucan from the cell to the extracellular milieu demonstrated reduced ECM glucan levels and decreased resistance to antifungal therapy [27] . Other ECM components, including extracellular DNA, also modulate drug resistance in biofilms produced by C. albicans and A. fumigatus, and in some instances, treatment of biofilms with DNase can reduce antifungal resistance [30, [38] [39] [40] [41] [42] . A. fumigatus biofilms similarly exhibit decreased susceptibility to azoles, echinocandins and polyenes [43] [44] [45] , including to amphotericin B. In addition, the co-administration of amphotericin B with alginate lyase, an enzyme that can degrade some exopolysaccharides within biofilms, was found to enhance the antifungal activity of amphotericin B against A. fumigatus biofilms, possibly by disrupting the polysaccharide component of the ECM and thus permitting drug access to hyphae [46] . These examples help to demonstrate the importance of having knowledge of ECM composition to provide insight into inhibitor modes of action and, ultimately, for developing strategies to combat the antifungal resistance exhibited by biofilms.
The ECM is often noted as a permeability barrier to antifungals that contributes to decreased drug susceptibility, although exceptions have been reported. One study utilized a disk diffusion assay to determine the C. albicans biofilm permeability of four antimicrobials: flucytosine, fluconazole, amphotericin B, and voriconazole [25] . Drug penetration through the biofilm failed to kill the cells, which suggested the existence of drug resistance mechanisms in addition to poor antifungal penetration for Candida biofilms. However, a previous study showed that the growth conditions (shaking above 30 rpm) used can inhibit ECM formation for C. albicans, as documented by scanning electron microscopy (SEM). Thus, further analysis is needed to probe effects on drug penetration [21, 25, 48] . Resistance can also be conferred to biofilm cells through the community's harboring of persister cells ( Figure 1B ) [24, 29, [49] [50] [51] . Persister cells are metabolically dormant cells that exhibit tolerance to multiple antifungals including amphotericin B, azoles, and chlorhexidine [30, 49, 50] . Finally, biofilm microbes also upregulate the production of efflux pumps to confer enhanced antibiotic resistance relative to microbes not associated with biofilms ( Figure 1C ) [28, 29, 52] . Increased expression of efflux pumps during biofilm growth has been observed for several Candida spp. and A. fumigatus, and resistance to azoles, drugs that disrupt ergosterol synthesis, is frequently due to increased expression of efflux pumps [30, 53, 54] .
The formidable survival traits of biofilms combined with our dwindling pipeline of effective antifungals make it imperative that we undertake in-depth analyses to improve upon our understanding of biofilms and ECM composition and function [55] [56] [57] . Indeed, standard antimicrobial susceptibility tests are still performed to examine the efficacy of single drugs using planktonically grown cultures, yet the biofilm state is often more relevant [3, 24] . Early descriptions of biofilms were often limited to 'slime', and this simplistic description masked the complexity of biofilms and slowed the design of biofilm inhibitors and interventions [20, 58] . The poor solubility and lack of crystallinity of biofilms and ECM render these materials especially challenging to examine using many traditional biochemical and biophysical techniques [19, 20, 59, 60] . Despite these challenges, recent studies have developed the necessary tools to measure and define quantitative parameters of biofilms and the ECM [3, 61, 62] . Here we review two approaches to annotate ECM composition with specific attention given to C. albicans and A. fumigatus, the most well-studied fungal systems and common causative agents of fungal infections in hospitalized patients. The first approach implements an arsenal of traditional biochemical methods to identify important ECM components, including identification via immunoassays [63] [64] [65] [66] ; and the second approach relies upon solid-state nuclear magnetic resonance (NMR) analysis of the intact ECM to profile the atomic-level contributions of unique classes of Fungal biofilm composition & opportunities in drug discovery Review biomolecules to the ECM [47] . Solid-state NMR uses the nuclear spin property to obtain information about chemical composition and structure, and can be used to examine any heterogeneous and insoluble materials, including whole cells and biofilm communities, and is not restricted to the study of soluble materials as many conventional methods are. The strengths and limitations of the two methods will be compared, and at the conclusion of this review, we discuss how these approaches might be used in the context of drug discovery to provide improved opportunities to effectively treat fungal infections.
Immunoassays to identify A. fumigatus ECM constituents Specific biomolecules can be identified using a range of indicator dyes, antibodies, and lectins [67] . Alternatively, the ECM constituents within each macromolecular class can be annotated through systematic biochemical analysis without prerequisite knowledge of putative ECM composition [65] . The first approach, using indicator dyes and antibody-and lectin-conjugated dyes, has been useful in fluorescence microscopy studies to identify and spatially resolve biofilm constituents [23, 32, [68] [69] [70] , and recent advances in superresolution microscopy have permitted the tracking of single proteins and polysaccharides during biofilm growth [71] . These studies have taught us that many ECM constituents appear to play complementary architectural roles and that localization of components within a biofilm can vary over time. It is important to note, however, that an inherent limitation of these studies is that they require prior knowledge of the b iofilm molecules of interest.
Immunoassays, which use antibodies that recognize specific molecules in order to identify or track the presence of that molecule, were useful to validate the presence of specific ECM polysaccharides and proteins in A. fumigatus biofilm, including biofilms formed in vitro and in vivo [63, 64] . Early work by Beauvais et al. revealed that the colony surface of A. fumigatus grown under aerial static conditions contained a hydrophobic ECM that bound hyphae in a manner that closely resembled in vivo 'fungal balls' [63] . Additionally, as predicted for biofilm, cultures grown under these conditions exhibited enhanced resistance to polyene antifungals relative to those grown under non-ECM-producing conditions (shaken, submerged). Interestingly, gentle mechanical removal of the ECM did not modify resistance to nystatin, which suggested that the A. fumigatus ECM may only reduce mycelial accessibility of some polyene antifungals, and in some cases additional biofilmspecific mechanisms may be responsible for antifungal resistance. Immunoassays and subsequent gas chroma-Review Reichhardt, Stevens & Cegelski tography identified galactomannan and α-1,3-glucans as A. fumigatus ECM components.
Glucose was identified as a major ECM component of in vitro A. fumigatus biofilms by monosaccharide analysis of digested ECM. Although the authors controlled for the possibility of contaminating glucose from the growth medium by culturing in glucose-free medium, it is important to recognize the general limitations of conditions used for monosaccharide analysis in many applications. To emphasize this, we highlight an example from work with the opportunistic human pathogen Pseudomonas aeruginosa. Until recently, Pel, which is an important extracellular polysaccharide of P. aeruginosa, was mistakenly believed to be a glucoserich molecule. This misidentification was due in part to the recalcitrance of Pel to isolation and standard preparatory hydrolysis conditions for monosaccharide compositional analysis [23] . Using harsher hydrolysis conditions for monosaccharide compositional analysis, Pel was determined to be a polymer of N-acetylglucosamine and N-acetylgalactosamine [23] . This assignment was supported by the reactivity of Pel to antibodies raised against poly-β-1,6-N-acetylglucosamine and chitosan (poly-β-1,4-N-acetylglucosamine) as well as binding to N-acetylgalactosamine-specific lectins.
Protein quantification assays also have limitations in their application to biofilm and ECM samples. The overall protein concentration of in vitro A. fumigatus ECM was found to be 2% (w/w) by the bicinchoninic acid (BCA) assay. However, this assay can incorrectly estimate protein concentration, as the complex molecular environment of the ECM can contain biomolecules such as glucose and lipids that can cause interfering absorbance in the presence of the BCA reagent or may limit accessibility of the protein peptide bonds to the BCA reagent (specifically Cu 2+ ions) [72] [73] [74] . The major antigens, DppV, catalase B and Asp f1, were identified by immunoblot, and the hydrophobic nature of the colony suggested the presence of hydrophobic proteins [75] . However, the contributions and identities of other potential proteins were not determined.
Despite the technical limitations of the above methods and inability to generate a complete accounting of the A. fumigatus ECM, the assays allowed an informative comparison between A. fumigatus ECM samples formed during host invasion, which was observed to depend upon whether the aspergillosis was localized (aspergilloma) or invasive (IPA) [64] . ECM was present in both pathological settings. However, hyphae in the IPA were separated and surrounded by a thinner layer of ECM relative to that of an aspergilloma. Aspergilloma appeared as a ball of strongly agglutinated hyphae, which was devoid of host cells and surrounded by a dense ECM network. Whole-biofilm immunoassays revealed that galactosaminogalactan (GAG) and galactomannan were major polysaccharides observed in the ECM, and α-1,3-glucan was only detected in aspergilloma at the periphery of the ECM. In vivo labeling with anti-GAG antibody was more intense as compared with in vitro labeling, suggesting that GAG was a major component of ECM produced during the development of A. fumigatus in tissues of patients with either aspergilloma or invasive aspergillosis. Later, it was observed that GAG mediates adherence to host cells, serves to control the host immune response by shielding β-glucans, and is a virulence factor that is required for biofilm formation [76] [77] [78] . The prevalence of GAG was later supported by studies using atomic force microscopy showing that GAG was highly exposed and able to serve as a fungal adhesin [79] . The biosynthesis of GAG has also been under study with efforts to understand the mechanism of deacetylation of residues in GAG, for example [80, 81] . Immunocytochemical assays performed with antibodies raised against the three major secreted antigens mentioned above (DppV, catalase B, and Asp f1), showed that these antigens were not embedded in the in vivo ECM [64] . Thus, the immunoassays of putative polysaccharide and protein components permitted comparative analysis of the ECM from in vitro and in vivo A. fumigatus biofilms and demonstrated that each system included many similar components such as GAG, galactomannan, α-1,3-glucans, and melanin. In addition, some components, such as the antigenic proteins, were enriched in the in vitro ECM but not detected in the in vivo ECM [63, 64] . These studies highlight the strengths of using immunoassays to detect particular predicted ECM components. However, this approach is limited to studying only predicted components as well as those for which specific antibodies are available. Furthermore, using this approach, it is not possible to quantify the contributions of each component in the total ECM.
Macromolecular screening for C. albicans ECM composition
Many of the biochemical methods available to identify ECM components were collectively implemented in a recent single study of C. albicans biofilm by Zarnowski et al. (Figure 2 ) [65] . In this study, the researchers first profiled the contributions to the crude ECM of each of the macromolecular classes: protein, polysaccharide, lipid, and nucleic acid. This initial profiling was performed using a combination of spectrophotometric and colorimetric assays. Specifically, the protein enrichment was determined to be 55% (w/w) using a BCA assay; the carbohydrate content was determined to be 25% (w/w) using the phenol- Fungal biofilm composition & opportunities in drug discovery Review sulfuric acid method; the nucleic acid concentration was determined to be 5% (w/w) using the absorbance of the crude ECM at 260 nm; and, finally, the remaining 15% (w/w) was assigned to lipid. The crude ECM was then processed in order to further characterize specific C. albicans ECM constituents using additional biochemical techniques. Specific proteins were identified using proteomic mass spectrometry following enzymatic digestion of crude matrix material. Most of the 565 identified proteins play a role in metabolism or in the production and modification of polysaccharides. Interestingly, when the proteomic analysis was repeated using in vivo biofilms formed in a rat catheter model, the majority of identified ECM proteins were mammalian, suggesting that host factors may greatly impact biofilm composition, a topic that warrants further study. Sequence analysis found that much of the nucleic acid was noncoding. Lipids were profiled using gas chromatography, and nearly all of the lipids were found to be glycerolipids.
Further analysis of the carbohydrate contributions to the ECM primarily relied upon monosaccharide analysis and solution NMR following purification and fractionation steps. Initially, size-exclusion chromatography identified both high-molecular weight and low-molecular-weight fractions that constituted 38.3 and 61.7% of the total carbohydrate, respectively. Monosaccharide analysis concluded that the highmolecular weight fraction was primarily mannose, while the low-molecular-weight fraction was mostly arabinose. 1D and 2D solution NMR analysis of the abundant neutral carbohydrate fractions supported the presence of both mannan and glucan residues, and the most-abundant mannan polysaccharide was investigated using small-angle x-ray scattering. While 2D correlative NMR methods were not able to identify a linkage between the mannan and glucan residues, a novel mannan-glucan complex was predicted based upon the constant ratio of each in chromatography fractions as well as colocalization of anti-mannan and anti-glucan antibodies observed in confocal imaging of in vitro biofilms. This colocalization also was observed in biofilms formed in vivo. As previously mentioned, β-1,3-glucan can bind to antifungals. However, only small amounts of matrix β-1,3-glucan were observed via immuno-TEM, suggesting that additional ECM components are likely able to sequester antifungals. This concept was explored using a solution-state 1 H NMR binding assay, in which linebroadening of matrix peaks suggested an interaction of the matrix with fluconazole. It was also determined that multiple ECM components were necessary for drug binding, which was further supported in a later study [82] .
This meticulous study provided new information about the relative abundance of the different macromolecules in C. albicans ECM that could be digested and accessed, and used this information to predict the presence of a novel exopolysaccharide complex [65] . However, many biofilms are resistant to the solubilization that is required for such solution-based analyses, and harsh degradative conditions are often used to attempt to overcome this challenge and generate some material for analysis [83, 84] . Furthermore, in addition to the previously stated limitations of the BCA assay to determine ECM protein concentration, the phenol-sulfuric acid method can incorrectly estimate the enrichment of carbohydrate. For the phenol-sulfuric acid method to be quantitative, the standard samples must contain representative portions of the types of monosaccharides found in the experimental sample, which is difficult to predict for complex carbohydrate mixtures such as ECM [85] . As a consequence of the limitations of these solution-based assays, estimates of contributions of proteins, polysaccharides, and other biomolecules can be dramatically misrepresented depending on the efficiency of the solubilization and the extent of material loss during sample processing, and extreme care should be taken when interpreting results from such analyses. These limitations, coupled with the importance of defining biofilm matrix composition as well as comparing biofilms and the influence of potential inhibitors, have encouraged the development of new approaches to help transform more qualitative biofilm descriptors into quantitative parameters of molecular composition [58, 59] .
Solid-state NMR to quantify A. fumigatus ECM composition
We recently developed an approach that utilizes solidstate NMR to quantitatively characterize and define biofilm and ECM composition [61, 86] . Solid-state NMR, in general, permits analysis of the entire, intact ECM without preparatory chemical or enzymatic processing. There is no intrinsic size or mass limit as in solution NMR, which requires high-molecular tumbling rates to achieve high-resolution NMR spectra [61] . More specifically, and as reviewed in more detail in the direct context of biofilm and ECM characterization, solid-state NMR employs magic-angle spinning to mechanically spin samples of multicellular biofilm communities or isolated ECM to help achieve the necessary resolution to obtain quantitative spectra of these heterogeneous and insoluble systems [61, 62] . Solid-state NMR has been applied to study other similarly complex and insoluble systems such as bacterial whole cells and cell walls [87] [88] [89] [90] [91] and intact plant leaves [92] . In 2013, we reported the first quantitative determination of the chemical composition of intact ECM of a microbial biofilm by using solid- Figure 2 . Schematic representation of a protocol employed to characterize the composition of Candida albicans biofilm. This methodology relies upon extensive processing of the biofilm and extracted matrix. Differences in solubilization efficiency of ECM components can result in compositional estimates that may vary widely from prep-to-prep [65] . An advantage of this approach, which uses an integrated effort, is the identification of specific matrix parts in the ECM, although there are caveats with quantification of these parts. BCA: Bicinchoninic acid; ECM: Extracellular matrix; GC: Gas chromatography; HPLC: High-performance liquidchromatography; LC-MS/MS: Liquid chromatography-mass spectrometry; NMR: Nuclear magnetic resonance; SAXS: Small-angle x-ray scattering. [86] . These initial experiments were performed on an important human pathogenic bacterium, the uropathogenic E. coli (UPEC) strain UTI89. We discovered that the spectral additional of just two components, the functional amyloid protein curli and a modified form of cellulose, completely recapitulated the 13 C NMR spectrum of intact UTI89 ECM. Thus, we determined that UTI89 ECM is 85% curli and 15% modified cellulose by mass. However, this bottom-up approach used for analysis of UTI89 required separate samples of putative ECM components, which are not readily known or available for many biofilm systems [61] .
C. albicans bio lm
To overcome this limitation, we developed an alternative top-down solid-state NMR approach that permits spectroscopic dissection and annotation of complex material and can be applied to biofilms or other multicomponent systems for which there is less known (or even nothing known) about potential constituents [61] . We first developed this method to examine Vibrio cholerae ECM composition, and as discussed below, subsequently implemented the top-down approach in Aspergillus fumigatus [61, 83] . This approach uses two types of 1D solid-state NMR experiments: cross-polarization magic-angle spinning (CPMAS) [93, 94] and rotational-echo double-resonance Fungal biofilm composition & opportunities in drug discovery Review (REDOR) [95] . The 13 C CPMAS spectrum contains information about the quantities of carbon types, including carbonyls, aromatic carbons, polysaccharide carbons (anomeric and nonanomerics) and aliphatics, present in the ECM. By ensuring full incorporation of 15 N into the matrix via defined growth medium, it is possible to further annotate the carbon pools according to C-N and C-P couplings using both 13 P}REDOR NMR experiments [61, 83] . We applied this top-down solid-state NMR methodology to quantify the ECM composition of the fungal A. fumigatus biofilm grown in RPMI 1640 nutrient medium (selected because of its optimum for growing mammalian cells) [47] . The 13 C CPMAS spectrum of A. fumigatus ECM showed contributions from a range of biomolecules ( Figure 3A) . To use CPMAS to quantify the number of nuclei at corresponding chemical shifts relative to others in a spectrum, differences in cross-polarization (CP) efficiency and relaxation must be taken into account. Such differences can arise due to variations in local dynamics and in the spatial distributions of 1 H nuclei in the sample that are coupled to the carbons. By way of experimental detail, we monitored the A. fumigatus ECM 13 C CPMAS intensities as a function of CP contact time, and observed a typical 'exponential rise-exponential decay' behavior that was extrapolated to zero contact time to quantify relative spin numbers. Together the 13 C CPMAS peaks due to polysaccharide anomeric and ring-sugar carbons, which are chemical shift resolved and thus were able to be uniquely assigned, accounted for approximately 43% of the total carbon mass.
To annotate the remaining 57% of the carbon mass, we capitalized on the unique C-N and C-P couplings that are present in different biomolecules ( Figure 3B & C) . For example, the 13 C spectrum of the ECM contained a peak near 173 ppm that was attributed to carbonyl carbons. Several types of biomolecules contain carbonyls, but all peptide carbonyl carbons are directly bonded to nitrogen ( Figure 3C ). Thus, by using 13 C{
15
N}REDOR as a spectroscopic filter to select only carbonyls that are directly bonded to nitrogen, we could determine an upper limit of the amount of protein carbonyls. Through determining the quantitative CPMAS peak intensities of different carbon types as described above, we discovered that the carbonyl peak accounted for 12% of the total 13 C spectrum of A. fumigatus ECM. Using 13 C{ 15 N}REDOR, we found that only 76% of the carbonyl carbons were directly bonded to nitrogen. Thus, at most, only 9% (76 of 12%) of total ECM carbon could be attributed to peptide carbonyls of proteins. The percentage of possible α-carbons was similarly determined to be 7% (including α-carbons of both glycine and other amino acids). Amino acids contain an average of 5.4 carbons each, and so three additional carbons can be generally attributed to protein. These carbons mostly would be observed in the upfield aliphatic region of the 13 C CPMAS spectrum. Together, this analysis supports that approximately 40% of the total carbon mass can be attributed to protein. The aromatic region of the 13 C CPMAS spectrum accounts for an additional 3% of the total carbon mass, which was partially attributed to melanin.
The remaining 14% of the 13 C CPMAS spectral area contains contributions from carbonyls and aliphatics (excluding directly nitrogen-bonded carbons), including a sharp peak at 33 ppm that is characteristic of CH 2 groups typically found in lipids and accounts for 7% of the total spectral area. Spectral selection of portions of these regions by 13 C{ 31 P}REDOR also suggested that the ECM contained some phospholipid. Thus, A. fumigatus ECM contained at least 7% lipid (due to the characteristic peak at 33 ppm) and up to 14% lipid by carbon mass. Taken together, the A. fumigatus ECM produced under these growth conditions was approximately 40% protein, 43% polysaccharide, 3% aromatic-containing components and up to 14% lipid.
Thus, atomic-level parameters of the intact isolated A. fumigatus ECM were measured and defined using the top-down solid-state NMR method. In addition, other valuable compositional parameters of the ECM constituents were obtained. The 15 N CPMAS spectrum showed that most of the ECM nitrogen is present in protein (appearing as an amide peak at 119 ppm). We were also able to detect low abundance nitrogen-containing motifs likely present as modifications to ECM constituents, for example, as amino or N-acetyl modifications. The 13 C{ 15 N}REDOR results suggested that some of the exopolysaccharides were N-acetylated based upon the presence of peaks attributed to N-acetyl methyl groups and the observed proximity of the nitrogen to some of the sugar-ring carbons. This finding is consistent with some of the previously identified extracellular polysaccharides produced by A. fumigatus including GAG. N-acetyl groups also could occur as part of the N-acetylglucosamine groups present in N-linked glycosylation of ECM proteins. The possibility that some of the extracellular proteins were glycosylated was explored using traditional biochemical analysis. SDS-PAGE analysis of the ECM showed several bands corresponding to SDS-soluble proteins, and these bands were excised and subjected to proteomic mass spectrometry. The SDS-soluble proteins were identified as catalase B and Asp f2. Consistent with the NMR spectral detection of N-acetyl groups, these two proteins are reported to be N-linked glycosylated. Digestion with peptide-Nglycosidase F (PNGase) resulted in cleavage consistent with glycosylation of Asp f2 in this ECM sample.
Importantly, the overall solid-state NMR approach provides absolute carbon intensities that can be compared across samples, whether due to different biofilm formers or the influence of external stimuli such as antibiofilm agents. We developed an approach to finely annotate the specific carbon types and to obtain a quantitative accounting of these pools in the biofilm ECM. Even quick inspection of the comparative 1D CPMAS spectra would permit facile identification of whether any significant differences were present among a sample set. Coupled with electron microscopy of intact biofilms and the isolated ECM material as well as biochemical analyses for the specific identification of some biofilm parts, we believe that this integrated approach with solid-state NMR analyses provides one of the most robust and powerful ECM characterization approaches available.
Conclusion
Connections between ECM composition and function are crucial to understanding the fundamental molecular basis for: fungal biofilm physiology, the recalcitrance of biofilm infections to antifungal treatment, and antifungal resistance. Robust and reliable methods to define and/or quantitatively compare ECM composition are crucial for driving these connections. The two major approaches to annotate ECM composition described in this review provide complementary details of ECM composition and connections with function. Solid-state NMR is uniquely suited to profile chemical composition of complex, insoluble systems like ECM [62] . The top-down solid-state NMR method described above can be applied to the study of any biofilm, including mixed species or in vivo-derived biofilms, and, importantly, does not require any prerequisite knowledge of biofilm composition [47, [61] [62] 83] . The approach first involves the annotation of the fundamental carbon and nitrogen compositional pools, for example, quantifying the prevalence of carbonyls and methyls, etc. It also takes advantage of poten- Fungal biofilm composition & opportunities in drug discovery Review tially unique internuclear couplings to further dissect ECM composition and to specify the types of carbonyls present, for example. The analysis is performed on the intact ECM and provides parameters not accessible from solution-based biochemical methods that require solubilization of ECM parts, wherein much of the ECM is often not analyzed due to its recalcitrance to digestion and dissolution. Furthermore, solid-state NMR analysis permits one to simultaneously observe and quantify multiple macromolecular species and a complete analysis can be performed on the same sample. The advantages of the solid-state NMR approach thus include the nondestructive nature of the analysis and the ability to quantify the types of nuclei present in a sample. A disadvantage, is the limited sensitivity of NMR and the relatively large sample sizes and/or long spectral acquisition times required to achieve high signal-to-noise spectra using natural abundance 13 C samples. Isotopically labeled samples improve sensitivity, although it is attractive that 13 C profiling, for example, does not require labeling and can be performed using 13 C at natural abundance. NMR correlation experiments provide additional selectivity to specify the specific nature of carbon pools that are annotated through 1D spectra. These experiments require isotopic enrichment, for example, as we demonstrated with 15 N-incorporation in a customized RPMI 1640 medium for the analysis of A. fumigatus ECM composition described above [47] . Thus, it is important to choose the right tool for the experiment, taking into account the problemsolving advantages and the technical limitations that can include sample solubility, processing requirements, and sample size.
Future perspective
Ideally, the traditional biochemical methods applied to solubilized parts of the ECM should be integrated with quantitative compositional profiling by solid-state NMR. The NMR analysis provides a total snapshot of molecular contributions to the intact ECM and the prevalence of molecules in the ECM, such as the relative abundance of proteins versus polysaccharides, including an analysis of types of chemical modifications present in the samples. Yet, while each protein has a unique NMR signature, identification of individual proteins in the ECM is best performed using proteomic mass spectrometry and immunoassays. Similarly, the identities of lipids and small, soluble polysaccharides can be determined using solutionbased biochemical methods on the individual purified components in isolation from one another. In addition to the study of complex, biomolecular mixtures, solid-state NMR can be applied to study in detail the isolated ECM components such as the high-molecularweight polysaccharide fractions identified in the previously described C. albicans study [65] , and does not require harsh, degradative conditions prior to analysis. In this way, solid-state NMR has been used to quantitatively determine structural information of similarly noncrystalline and insoluble bacterial [88, 90, 91, 96] and plant cell walls [97] [98] [99] [100] .
Solid-state NMR also is well suited for the study of drug-matrix interactions, with inspiration from studies that mapped atomic-level interactions of the antibiotic [
19 F]oritavancin with S. aureus cell walls (both in isolated cell walls and in the whole-cell context) by measuring several 19 F-13 C and 19 F-15 N distances between drug and specific cell-wall sites [87] . In the realm of antifungals, solid-state NMR approaches have been used to examine the possible mechanism(s) of action of amphotericin B in lipid vesicle systems used as surrogates for fungal membranes. Most structural studies have characterized the pore-forming assemblies of amphotericin [101] , yet very recent solidstate NMR work examined samples prepared with phospholipids, ergosterol and amphotericin, and showed that amphotericin B could extract ergosterol out of phospholipids, and serve as a type of ergosterol sponge [102] . These types of structure-focused NMR approaches are ripe for identifying specific ECM components that bind to antifungals and for mapping the interactions between the ECM and 19 F-labeled drugs, for example. Together, solid-state NMR methods enable the quantification of the abundance of biomolecules in a biofilm and can be used to determine the ways in which the components could be interacting with antifungals to contribute to the antifungal r esistance often exhibited by biofilms.
The ECM is able to inhibit the access of some antifungals to fungal cells in a biofilm and contributes to the challenge of treating biofilm-associated infections. The potential mechanisms of ECM-mediated antifungal recalcitrance include both matrix-matrix interactions and matrix-drug interactions. For example, the matrix could be self-associating to form an impenetrable barrier to drugs. Alternatively, the matrix could either bind to drugs or enzymatically inactivate the drugs, both of which prevent antifungals from reaching their intended target at the surface of or within the fungal cell. The ECM composition plays a key role in dictating the possible mechanisms that biofilms employ to decrease susceptibility to antifungals. In the past, knowledge of ECM composition has given rise to more effective strategies to treat biofilm-involved fungal infections such as the coadministration of amphotericin B with alginate lyase to degrade exopolysaccharides and enhance the antifungal activity of amphotericin B against A. fumigatus biofilms [46] . As knowledge of • Many prescribed antifungal drugs are not effective against biofilm infections owing to several protective factors including poor diffusion of drugs through biofilms as well as specific drug-matrix interactions.
• Both Candida albicans and Aspergillus fumigatus form biofilms, and these biofilms are involved in a range of human infections, including lethal fungal infections among immunosuppressed individuals.
• A defining feature of biofilms is the extracellular matrix (ECM), which is a self-produced, noncrystalline material that encases microbial cells. ECM is typically rich in biopolymers and can contain proteins, polysaccharides, lipids, nucleic acids, and other molecules.
• The formidable survival traits of biofilms combined with our dwindling pipeline of effective antifungals make it imperative that we undertake in-depth analyses to improve upon our understanding of biofilms.
• The two approaches, traditional biochemical methods and a newly developed solid-state NMR method, can be used to annotate ECM composition and provide complementary perspectives on ECM composition and function.
Immunoassays to identify A. fumigatus ECM constituents
• Immunoassays were useful to validate the presence of specific ECM polysaccharides and proteins in A. fumigatus biofilm, including both in vitro and in vivo biofilms.
• Immunoassays and subsequent gas chromatography identified galactomannan and α-1,3-glucans as A. fumigatus ECM components.
• The major antigens, DppV, catalase B and Asp f1, were identified by immunblot in the in vitro ECM but were not detected in the in vivo ECM.
Macromolecular screening for C. albicans ECM composition
• The ECM of Candida albicans was examined and the contributions of each of the macromolecular classes were profiled.
• This initial profiling was performed using a combination of spectrophotometric and colorimetric assays, and the ECM was determined to be 55% (w/w) protein, 25% (w/w) carbohydrate, 5% (w/w) nucleic acid, and 15% (w/w) lipid.
• Carbohydrate characterization primarily relied upon monosaccharide analysis and solution nuclear magnetic resonance (NMR) following purification and fractionation steps, and both high-molecular-weight and lowmolecular-weight fractions were identified.
• Many biofilms are resistant to the solubilization that is required for such solution-based analyses, and harsh degradative conditions are often used to overcome this challenge which can lead to misrepresentations of ECM composition.
Solid-state NMR to quantify A. fumigatus ECM composition
• A solid-state NMR approach was developed that permits analysis of the entire, intact ECM without preparatory chemical or enzymatic processing.
• Solid-state NMR does not require high tumbling rates in solution (solution NMR) or homogeneous samples, and provides quantitative information about composition.
• This solid-state NMR approach uses two types of 1D NMR experiments: cross-polarization magic-angle spinning (CPMAS) and rotational-echo double-resonance (REDOR).
• Spectral dissection using solid-state NMR determined that the A. fumigatus ECM was approximately 40% protein, 43% polysaccharide, 3% aromatic-containing components, and up to 14% lipid.
• In addition to the atomic-level parameters of A. fumigatus ECM gained using this top-down solid-state NMR method, general characteristics of the ECM constituents were obtained including glycosylation of extracellular proteins and types of modifications of exopolysaccharides.
Opportunities in drug discovery
• Measurements of ECM composition are crucial to understanding fungal biofilm physiology, the recalcitrance of biofilm infections to antifungal treatment, and antifungal resistance.
• Integrated approaches employing electron microscopy, biochemical methods including proteomics analyses, together with solid-state NMR compositional measurements would allow for comprehensive characterization and elucidation of the generation of quantitative parameters of ECM composition, enabling comparisons with samples from organisms treated with antifungal and antibiofilm agents.
• Solid-state NMR approaches can be used to map the ECM binding sites and bound conformations of candidate therapeutics in isolated ECM and in intact cells.
future science group
Fungal biofilm composition & opportunities in drug discovery Review biofilm composition, including composition of mixed species and in vivo biofilms increases, we believe that effective strategies to treat biofilm-involved fungal infections will also improve. Knowledge of the ECM composition provides evidence of which mechanisms could be in play for a particular biofilm, and furthermore, provides routes to overcome the matrix-mediated antifungal resistance. These routes may involve combined antifungal and anti-virulence approaches. For example, the biophysical and biochemical ways in which the ECM is able to act as a drug barrier could be taken into account when designing an antifungal drug so that the drug meets size, charge, and reactivity requirements to be able to pass through the biofilm and impact the fungal cells. Complementary anti-virulence approaches could block matrix-matrix or matrix-drug interactions, either through co-administration of additional drugs or through mechanical disruption. Specific knowledge of those matrix-matrix and matrix-drug interactions is crucial to the design of such therapeutics. Thus, compositional and molecular-level descriptions of the ECM should help to drive the development of strategies to eradicate biofilm-associated infections and develop more effective antifungal treatments.
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